Skip to main content

. 1989 Feb 18;298(6671):432. doi: 10.1136/bmj.298.6671.432

Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody.

M Youle ¹, J Clarbour ¹, C Farthing ¹, M Connolly ¹, D Hawkins ¹, R Staughton ¹, B Gazzard ¹

PMCID: PMC1835649 PMID: 2495052

432

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Barr C. E., Torosian J. P. Oral manifestations in patients with AIDS or AIDS-related complex. Lancet. 1986 Aug 2;2(8501):288–288. doi: 10.1016/s0140-6736(86)92109-4. [DOI] [PubMed] [Google Scholar]
Grinspan D. Significant response of oral aphthosis to thalidomide treatment. J Am Acad Dermatol. 1985 Jan;12(1 Pt 1):85–90. doi: 10.1016/s0190-9622(85)70014-x. [DOI] [PubMed] [Google Scholar]
Moncada B., Baranda M. L., González-Amaro R., Urbina R., Loredo C. E. Thalidomide--effect on T cell subsets as a possible mechanism of action. Int J Lepr Other Mycobact Dis. 1985 Jun;53(2):201–205. [PubMed] [Google Scholar]
Torras H., Lecha M., Mascaro J. M. Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis. Arch Dermatol. 1982 Nov;118(11):875–875. [PubMed] [Google Scholar]

ACTIONS

RESOURCES